Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects

被引:0
|
作者
Weng, Hao-Jui [1 ,2 ,3 ]
Quoc Thao Trang Pham [3 ,4 ]
Chang, Chia-Wei [2 ]
Tsai, Tsen-Fang [5 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Dermatol, New Taipei 23561, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Dermatol, Taipei 11031, Taiwan
[3] Taipei Med Univ, Coll Med, Int PhD Program Cell Therapy & Regenerat Med, Taipei 11031, Taiwan
[4] Univ Med & Pharm Ho Chi Minh City, Fac Med, Dept Dermatol, Ho Chi Minh City 70000, Vietnam
[5] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100225, Taiwan
关键词
pain; pruritus; neuropathy; NERVE GROWTH-FACTOR; ACTIVATED RECEPTOR 2; TOXIN TYPE-A; HISTAMINE-INDUCED ITCH; OPIOID-INDUCED ITCH; ATOPIC-DERMATITIS; NEUROPATHIC PAIN; SECONDARY HYPERALGESIA; DOUBLE-BLIND; POSTHERPETIC NEURALGIA;
D O I
10.3390/ph15070892
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pain and itch are both important manifestations of various disorders, such as herpes zoster, atopic dermatitis, and psoriasis. Growing evidence suggests that both sensations have shared mediators, overlapping neural circuitry, and similarities in sensitization processes. In fact, pain and itch coexist in some disorders. Determining pharmaceutical agents and targets for treating pain and itch concurrently is of scientific and clinical relevance. Here we review the neurobiology of pain and itch and discuss the pharmaceutical targets as well as novel compounds effective for the concurrent treatment of these sensations.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites
    Merritt, Christopher
    Silva, Lisseth E.
    Tanner, Angela L.
    Stuart, Kenneth
    Pollastri, Michael P.
    CHEMICAL REVIEWS, 2014, 114 (22) : 11280 - 11304
  • [32] Druggable targets for the immunopathy of Alzheimer's disease
    Weaver, Donald F.
    RSC MEDICINAL CHEMISTRY, 2023, 14 (09): : 1645 - 1661
  • [33] Cysteine metabolic circuitries: druggable targets in cancer
    Vasco D. B. Bonifácio
    Sofia A. Pereira
    Jacinta Serpa
    João B. Vicente
    British Journal of Cancer, 2021, 124 : 862 - 879
  • [34] Tankyrases Are Druggable Targets for the Treatment of Metabolic Disorders
    Obianom, Obinna
    Yang, Wei
    Xue, Fengtian
    Shu, Yan
    FASEB JOURNAL, 2016, 30
  • [35] Atlas of therapeutic targets: Evolution of druggable proteome
    Babic, Ivan
    Nurmemmedov, Elmar
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Novel Biomarkers and Druggable Targets in Advanced Melanoma
    Ferrucci, Pier Francesco
    Cocorocchio, Emilia
    CANCERS, 2022, 14 (01)
  • [37] Hemostatic Factors as Druggable Targets in Diverse Pathologies
    McDowell, Susan A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (09) : 1440 - 1440
  • [38] A STUDY OF THE ANTIPRURITIC EFFECTS OF TOPICAL STEROIDS
    FRANK, L
    ARCHIVES OF DERMATOLOGY, 1958, 77 (04) : 433 - 434
  • [39] Antipruritic effects of the fruits of Chaenomeles sinensis
    Oku, H
    Ueda, Y
    Ishiguro, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (07) : 1031 - 1034
  • [40] Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
    Wang, Xin
    Gou, Xiaoli
    Yu, Xiaojuan
    Bai, Dongdong
    Tan, Bowei
    Cao, Pingfeng
    Qian, Meilin
    Zheng, Xiaoxiao
    Wang, Hairong
    Tang, Pingming
    Zhang, Chen
    Ye, Fei
    Ni, Jia
    FRONTIERS IN PHARMACOLOGY, 2021, 12